Progressive vaccinia treated with ribavirin and vaccinia immune globulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9356807.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 67-year-old man with metastatic melanoma and chronic lymphocytic leukemia was inadvertently given a vaccinia melanoma oncolysate vaccination. He developed progressive vaccinia at the site of inoculation. The lesion started to heal only when he was treated with ribavirin. Vaccinia immune globulin was administered and appeared to help control the initial lesion and limit the development of satellite lesions.
Medical subject headings
- Antibodies, Viral
- Antiviral Agents
- Ribavirin
- Vaccinia